Review
Open access
Jul 2026
Radiomics and clinical data predict pseudoprogression after radiotherapy in high-grade glioma
The integrated model showed acceptable internal validation performance and provided a clinically interpretable framework for individualized PsP risk estimation by combining radiomic, perfusion-diffusion, inflammatory, molecular, and treatment-related information.
Zhou Jiang, Danmeng Zhang, Hui Yang et al.
· Frontiers in Oncology · 0 citations